Clinical Trials Logo

Clinical Trial Summary

Adult patients with suspected or confirmed infection and who will be sampled for blood culture will be recruited. Blood samples are collected for the analysis of matrix metalloproteinases (MMP) and their inhibitors. We also aim to analyse metabolic changes and use the samples for analysis of blood lactate, metabolomics, and fibroblast growth factor 21 (FGF-21) as well. The primary aim of the study is to test the performance of MMP-8 in finding severely ill patients who will need treatment in high dependency unit or intensive care. The secondary aim is to study the metabolic changes in acutely ill patients with infection.


Clinical Trial Description

Adult patients with suspected or confirmed infection and who will be sampled for blood culture (a surrogate for suspected severe infection) will be recruited from three large emergency departments in a University hospital. Two blood samples will be collected: one for the analysis of matrix metalloproteinases, their inhibitor tissue inhibitor of metalloproteinase-1 (TIMP-1), FGF-21 and metabolomic analyses. Another blood sample is for the analysis of blood lactate. Clinical data will be collected to calculate quick SOFA (qSOFA), in order to test whether lactate and/or MMP-8 will improve the prognostic model if they are added to qSOFA. The primary outcome measure is the number of days alive without the need for ICU or high dependency unit treatment. The ability of MMP-8 to discriminate severe infection from uneventful course of the disease will be studied. The secondary aim is to study the metabolic changes in acutely ill patients with infection and compare these variables between survivors and non-survivors. The planned number of patients recruited is 924. During this study the feasibility of a bedside rapid analysis of MMP-8 will be tested in 30 patients and the results obtained using the rapid analyser compared with laboratory results obtained using ELISA. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03494790
Study type Observational
Source Helsinki University
Contact Johanna Hästbacka, MD, PhD
Phone +350504286701
Email johanna.hastbacka@hus.fi
Status Recruiting
Phase
Start date December 15, 2017
Completion date January 31, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT02714595 - Study of S-649266 or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens Phase 3
Recruiting NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Enrolling by invitation NCT03258684 - Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock N/A
Recruiting NCT03295825 - Heparin Binding Protein in Early Sepsis Diagnosis N/A
Not yet recruiting NCT03562689 - Cognitive Processing in Patients Surviving Delirium. Neuropsychological, EEG and Structural Brain Correlates.
Not yet recruiting NCT03167788 - Red Cell Rejuvenation for the Attenuation of Transfusion Associated Organ Injury in Cardiac Surgery Phase 2
Not yet recruiting NCT03213990 - Beta-Lactam InfusioN Group Study N/A
Recruiting NCT02930070 - qSOFA in General Wards: the Accuracy in Diagnosis of Sepsis N/A
Recruiting NCT02907931 - Carotid Doppler Ultrasound for the Measurement of Intravascular Volume Status N/A
Recruiting NCT02899143 - Short-course Antimicrobial Therapy in Sepsis Phase 2
Recruiting NCT02922998 - CD64 and Antibiotics in Human Sepsis N/A
Recruiting NCT02565251 - Volemic Resuscitation in Sepsis and Septic Shock N/A
Recruiting NCT02567305 - Neutrophil Extracellular Traps and Neonatal (PV4991) & Pediatric Sepsis (PV5063) N/A
Completed NCT02467023 - Project 4B: Lower Extremity Strength Training in ICU Patients N/A
Recruiting NCT02914756 - HMGB1 in ICU-survivors N/A
Recruiting NCT02883218 - Dynamic Alterations of Th2/Th1 With New Onset of Community-acquired Severe Sepsis Patients
Recruiting NCT02210169 - RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates N/A
Completed NCT02400697 - Placental Transfusion Project for Preterm Infants N/A
Completed NCT02079402 - Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care Phase 4
Recruiting NCT02544490 - Defining Circulating Micro-RNA Biomarkers for the Early Diagnosis and Prognosis of Sepsis N/A